<DOC>
	<DOCNO>NCT01014013</DOCNO>
	<brief_summary>The purpose study determine efficacy ertapenem sodium ( Invanz ) treatment complicate urinary tract infection respect proportion patient favorable microbiological response 5-9 day post therapy .</brief_summary>
	<brief_title>Safety Tolerability Ertapenem Sodium Treatment Complicated Urinary Tract Infections ( 0826-055 )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<criteria>Adult patient suspect documented complicate urinary tract infection Female patient must test negative pregnancy agree use adequate birth control measure Nursing woman must agree defer breastfeed 5 day completion study antibiotic therapy Patients complete obstruction portion urinary tract Patients rapidly progressive terminal illness Renal transplant patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>